Skip Navigation LinksHome > July 2009 - Volume 4 - Issue 4 > Global epidemiology of HIV
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e32832c06db
Epidemiology: Edited by Tim Mastro and Quarraisha Abdool-Karim

Global epidemiology of HIV

Kilmarx, Peter H

Free Access
Article Outline
Collapse Box

Author Information

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Correspondence to Peter H. Kilmarx, MD, 1600 Clifton Road, MS E-45, Atlanta, GA 30333, USA Tel: +1 404 639 8998; fax: +1 404 639 6127; e-mail: pbk4@cdc.gov

Collapse Box

Abstract

Purpose of review: To provide an update on the epidemiology of HIV worldwide and by region, along with an overview of recent HIV epidemiological research.

Recent findings: The global prevalence of HIV-1 has stabilized at 0.8%, with 33 million people living with HIV/AIDS, 2.7 million new infections, and 2.0 million AIDS deaths in 2007. Heterosexual spread in the general population is the main mode of transmission in sub-Saharan Africa, which remains the most heavily affected region, with 67% of the global burden. Male–male sex, injection drug use, and sex work are the predominant risk factors in most other regions. Infection rates are declining in some regions, including some of the most heavily affected countries in Africa, but climbing elsewhere such as in eastern Europe and central Asia. Recent HIV epidemiologic research findings include new insights into the role of HIV viral load, co-infection with sexually transmitted infections, male circumcision, antiretroviral treatment, serosorting, and superinfection in HIV transmission and prevention.

Summary: The global prevalence of HIV has stabilized in this decade, but with important regional differences in trends and modes of transmission. Prevention and treatment programs have an expanding impact in preventing HIV infection and AIDS deaths.

Back to Top | Article Outline

Introduction

This overview summarizes the epidemiology of HIV-1 worldwide and by region in 2007, the latest available surveillance data from the Joint United Nations Program on HIV/AIDS (UNAIDS). An update is also provided on important new research findings in HIV epidemiology, with an emphasis on studies relevant to HIV prevention, systematic reviews, and meta-analyses. Other articles in this special issue and reviews published elsewhere provide more complete background information and discussions of the topics in this review article.

Back to Top | Article Outline

Global epidemiology of HIV/AIDS

In this decade, the global prevalence of HIV-1 infection stabilized at 0.8% (estimate range, 0.7–0.9%) (Table 1) [1••]. However, the overall number of people living with HIV increased as new infections continued to occur and AIDS deaths were prevented by increasingly available highly effective antiretroviral treatment (ART). Globally, there were an estimated 33.2 million (estimate range, 30.6–36.1 million) people living with HIV infection or AIDS in 2007, an increase from 29.5 million in 2001 [1••]. The annual incidence of new HIV infections declined from an estimated 3.0 million in 2001 to an estimated 2.7 million (estimate range, 2.2–3.2 million) in 2007. There were an estimated 2.0 million (estimate range, 1.8–2.3 million) HIV-related deaths in 2007. This number represents an increase from 1.7 million deaths in 2001, but as access to treatment increased in this decade, the annual numbers of deaths peaked in 2005 and subsequently decreased. From 2002 to 2007, the number of people receiving ART in developing countries increased from 300 000 to 3.0 million, which was 31% of those who needed treatment [2••].

Table 1
Table 1
Image Tools

Globally, the percentage of people with HIV infection who are women has remained stable at 50% for several years [1••]. Adolescents and young adults aged 15–24 years account for 45% of new HIV infections worldwide. An estimated 370 000 (estimate range, 330 000–410 000) children aged 14 years or less were infected in 2007. This number has declined since 2002 as access to interventions to prevent mother–infant transmission have expanded. Availability of antiretroviral medicines to HIV-positive pregnant women for prevention of mother–child HIV transmission in developing countries increased from 9% in 2004 to 33% in 2007 [2••]. However, the number of children living with HIV has increased from 1.6 million in 2001 to 2.0 million (estimate range, 1.9-2.3 million) in 2007 [1••]. More than 96% of new infections are in low-income and middle-income countries [2••].

The global pandemic may be described in two broad patterns [2••]. In many countries, mostly in sub-Saharan Africa, particularly southern Africa, and some countries in the Caribbean, there are generalized epidemics with heterosexual transmission in the general population. Secondly, HIV disproportionately affects injection drug users (IDUs), men who have sex with men (MSM), and sex workers (both female and male) worldwide, including in most areas that also have generalized epidemics. The elevated risk to MSM in developing as well as developed countries was recently underscored in a meta-analysis comparing reported HIV prevalence data in MSM with the prevalence in reproductive-age adults. By region, the pooled odds ratio for MSM men was 33.3 in the Americas, 18.7 in Asia, and 3.8 in Africa [3•].

The global statistics mask important local and regional epidemiologic heterogeneity. There were encouraging reductions in prevalence in some countries, notably in sub-Saharan Africa, whereas infection rates increased in others, such as in eastern Europe and central Asia [2••]. It should also be noted that UNAIDS global and key regional estimates in 2007 were lower than those published in 2006, owing largely to new data indicating that previous estimates had been too high [4]. Specifically, results from multiple population-based surveys generally indicated lower HIV prevalences than did those from sentinel site surveillance. Updated assumptions and methods based on that information were applied retrospectively to earlier data, thus the UNAIDS trend data reported here, including the global stabilization in prevalence and declines in some regions, are not simple the result of changing assumptions and methodology over time.

Overall, prevention program coverage remains incomplete. In 2005–2007, an estimated 60% of female sex workers (39 countries reporting) and 40% of MSM (from 27 countries) reported knowing where they can receive an HIV test and that they had been given condoms [2••]. For IDUs, an estimated 46% (from 15 countries) reported knowing where they could receive an HIV test and be provided with condoms and sterile injecting needles and syringes [2••].

Back to Top | Article Outline
Sub-Saharan Africa

This region is the most heavily affected by HIV, accounting for 67% of all people and 90% of children living with HIV worldwide and 75% of AIDS deaths in 2007 (Table 1) [1••]. There have been gains in availability of ART, but AIDS remains the leading cause of death in the region. In Malawi, for example, mortality in AIDS-affected age groups declined when access to free ART was scaled up in 2004–2006 [5]. Within sub-Saharan Africa, there is considerable heterogeneity in the severity of the epidemic. Prevalence in most west African countries is less than 2%, whereas the prevalence is greater than 20% in three Southern African countries [2••]. A recent mathematical modeling study highlighted the importance of male circumcision in accounting for sub-regional differences because of the effect on transmission of HIV as well as other sexually transmitted infections which facilitate HIV transmission [6•].

Most transmission in sub-Saharan Africa is through heterosexual transmission in the general population [2••]. Sex work is prevalent, but in a five-country study, sex work accounted for a relatively small proportion of new infections [7•]. Male–male sex is also an increasingly recognized mode of transmission [8]. A substantial proportion of heterosexual HIV transmission in Africa occurs among HIV-discordant stable couples, an estimated 55–93% in one study [9•]. A review of population-based surveys in west, central, and east Africa determined that at least two-thirds of the infected couples are discordant and, contrary to general perceptions that the male almost invariably introduces HIV into the dyad, the female is the infected partner in 30–40% of cases [10].

Infection rates appear to have reached a plateau in many countries, whereas there are significant declines in others [2••]. HIV prevalence in 15–24-year-olds may be used as a measure of recent trends in behavior change and HIV infection rates. The prevalence in pregnant women age 15–24 years has declined since 2000–2001 in 14 of 17 African countries with adequate data [2••]. Most striking, in Kenya HIV prevalence among young pregnant women declined by more than 25% in both urban and rural areas, whereas similar declines were observed in urban areas of Côte d'Ivoire, Malawi and Zimbabwe, and rural parts of Botswana. Reported trends in risk behavior show more mixed results and suffer from a significant variability in methods and quality from year to year and from country to country. The proportion of young people who reported having had sex with nonregular partners in the previous year decreased for both men and women in some countries, for women only in others, and increased for both sexes in others. There are more consistent reported increases in condom use by young people of both sexes during last sex with nonregular partners; however, that increased for women only in other countries and decreased for men in others. Although, in part, the regional reduction in HIV incidence likely reflects natural trends in the epidemic [11•], taken together, trends in decreasing risk behaviors with decreasing HIV prevalence suggest that prevention efforts are having an impact in some of the most-affected countries.

Which specific changes in sexual behavior may account for observed reductions in HIV transmission has been a controversial issue. A recent review of multiple data sources on the behavior changes that resulted in the reduction in HIV prevalence in Uganda in the late 1980s and early 1990s concluded that Ugandans initially reduced the number of extra-marital sex partners and subsequently increased condom use with extra-marital partners [12••]. This finding suggests that prevention programs should not target a single risk behavior.

Back to Top | Article Outline
Asia

In Asia, there were about 5 million people with HIV infection in 2007, with an estimated 380 000 new infections and 380 000 AIDS deaths (Table 1) [1••]. As the epidemic matures in the region, there has been an overall decrease in the annual number of new infections and an increase in AIDS deaths since 2001. National trends in the region vary considerably. Prevalence is decreasing in Burma, Cambodia, and Thailand, whereas increasing rapidly in Pakistan, Vietnam, and some provinces of Indonesia [2••]. Rates of new infections are also increasing slowly in the very populous countries of Bangladesh and China. Injection drug use, sex work, male–male sex, and overlap in these behaviors continue to drive the spread of HIV in most Asian countries [2••]. Three cross-sectional surveys measuring the prevalence of HIV among MSM in Beijing in 2004, 2005, and 2006 documented an increasing HIV prevalence from 0.4% in 2004 to 4.6% in 2005 and 5.8% in 2006 [13].

Back to Top | Article Outline
Eastern Europe and central Asia

Since 2001, the number of people with HIV in eastern Europe and central Asia increased from 650 000 to 1.5 million in 2007 (Table 1) [1••]. The annual number of new infections has declined, largely due to a slowing of the epidemic in the Russian Federation, where new infections increased sharply in the late 1990s and peaked in 2001 [2••]. At 1.6% in 2007, prevalence in Ukraine is the highest in Europe or central Asia [14]. Incidence in Ukraine has more than doubled since 2001 and is increasing in central Asian countries also including Uzbekistan, which has the largest epidemic in central Asia. Together, the Russian Federation and Ukraine accounted for 90% of the new infections in the region in 2005 [1••]. Injection drug use and sex work largely fuel the epidemic, whereas male–male sex is likely an underreported factor [2••]. Of cases in the region reported in 2006 for which the mode of transmission was known, 62% were due to injection drug use and 37% were from heterosexual transmission. About 40% of reported new infections were in women, of them, an estimated 35% were infected through injection drug use, whereas another 50% acquired infection from drug-using partners [15].

Back to Top | Article Outline
Caribbean

The epidemic has remained relatively stable in the Caribbean (Table 1) [1••], with some declines in incidence in urban areas in Haiti and the Dominican Republic; the two countries account for about three quarters of people with HIV living in the region [2••]. Heterosexual transmission is the predominant mode of transmission in the region, whereas male–male sex is an important factor in some countries [2••].

Back to Top | Article Outline
Latin America

HIV trends in Latin America have also been relatively unchanged in the past decade (Table 1) [1••], with most transmission attributed to male–male sex and sex work [2••]. In a recent study in five central American countries, HIV seroprevalence in MSM ranged from 7.6 to 15.3%, and estimated incidence ranged from 2.7 to 14.4 per 100 person-years [16]. For female sex workers, HIV seroprevalence ranged from 0.2% to a high of 9.6% in Honduras, where estimated HIV seroincidence was 3.2 per 100 person-years [16].

Back to Top | Article Outline
North America

Incidence has been fairly stable in North America (Table 1) [1••], although recent estimates indicate that incidence was higher than previously thought in the USA [17•]. With life-saving ART widely available, the numbers of people living with HIV has increased. Male–male sex remains the most important mode of transmission, followed by heterosexual transmission, whereas transmission attributed to injection drug use has declined [2••]. Recent reports in the USA highlight racial and ethnic disparities in the burden of disease. The estimated incidence of HIV per 100 000 population in 2006 was 115.7 in black men, 43.1 per 100 000 in Hispanic men, and 19.6 in white men [18]. For women, the rates were 83.8, 29.4, and 11.5, respectively. Another recent insight into HIV epidemiology has been gained through an analysis of the rate of HIV transmission from infected individuals [19]. The estimated rate has declined from 92 per 100 persons living with HIV/AIDS in 1980 when infection was rapidly spreading before the epidemic was detected to 44 per 100 in 1984. In the last decade, transmission has further decreased from eight per 100 in 1997 to five per 100 in 2006, the most recently available data.

Back to Top | Article Outline
Western and central Europe

Overall trends are relatively stable in western and central Europe (Table 1) [1••] with considerable diversity among countries. Heterosexual transmission accounts for the largest share of transmission, with a substantial proportion in western Europe among persons born in sub-Saharan Africa and the Caribbean [2••]. Incidence in men who have sex with men has increased in recent years in western Europe, along with reports of increases in unprotected sex [20••]. Transmission among IDUs has decreased, although it remains the main mode of transmission in Estonia, Latvia, Lithuania, and Poland [2••].

Back to Top | Article Outline
Middle East and North Africa

The limited information from the Middle East and North Africa indicate a relatively low prevalence of 0.3% and relatively stable trends with an estimated 40 000 persons newly infected in 2007 (Table 1) [1••]. Injection drug use and sex work are the main transmission risk factors. Sudan has the highest number of persons infected, with heterosexual intercourse as the main mode of transmission [2••].

Back to Top | Article Outline
Oceania

Although relatively concentrated in Papua New Guinea, the HIV epidemic is increasing in Oceania with 13 000 new infections in 2007 (Table 1) [1••]. The number of new cases doubled in that country from 2002 to 2006. The main mode of transmission is heterosexual sex, with significant proportions of men reporting patronage of female sex workers. Transmission attributed to male–male sex is the main mode in Australia and has increased in recent years [2••].

Back to Top | Article Outline

HIV transmission

Several recently published studies, systematic reviews, and meta-analyses of HIV transmission topics are especially relevant to HIV prevention. A systematic review and meta-analysis shed new light on the risk of HIV-1 transmission per heterosexual contact in high-income versus low-income countries. In high-income countries in the absence of ART, overall female-to-male (0.04% per act) and male-to-female (0.08% per act) transmission rate was relatively low compared with low-income countries where, outside the commercial sex context, the female-to-male per-act estimate was 0.38% and the male-to-female rate was 0.30%. The per-act transmission risk estimate for receptive anal intercourse was much higher (1.7%). Rates were also higher in the early and late phases of HIV infection than for the asymptomatic latent phase, with genital ulcers in either couple member, and in uncircumcised versus circumcised men [21••].

Further highlighting the disproportionate role of the acute infection period in HIV transmission, a study using phylogenetic analysis to characterize the short-term dynamics of the epidemic among MSM in London estimated that 25% of transmission events occurred within 6 months after infection [22]. A similar study in Canada estimated that up to half of subsequent transmission was in the acute infection period [23•]. However, a mathematical modeling study indicated that in Africa no stage of infection is dominant in driving the epidemic, with the early, latent, and late stages contributing 17, 51, and 32%, respectively, to transmission in Kisumu, Kenya, whereas the estimate was 25, 44, and 31%, respectively, in Yaoundé, Cameroon [24•].

A case–control study of MSM being evaluated for primary HIV infection and their recent male sex partners underscored the importance of viral load in HIV transmission [25••]. Fifteen HIV-transmitting men had a higher median seminal plasma viral load (SVL) and median blood plasma viral load (BVL) than did 32 men who did not transmit. BVL and SVL are not necessarily highly correlated; a review of 19 studies on the association found a mean correlation coefficient of 0.45 (range = 0.07–0.64) [26]. BVL was usually higher than SVL, but varied depending on the presence of other STD and ART use.

Another systematic review and modeling study suggested that prevention and treatment of co-infections such as tuberculosis and herpes simplex virus type 2 (HSV-2) infections may result in modest reduction in BVL even without ART and thereby both slow disease progression and reduce infectiousness [27].

Back to Top | Article Outline

Sexually transmitted infections

A recent systematic review and meta-analysis confirmed that genital tract infections increase both the detection and the concentration of HIV-1 in the genital tract, particularly when the infection is symptomatic [28]. In the above-mentioned MSM case–control study, positive HSV-2 serostatus was associated with the risk of transmission but not acquisition of HIV [25••]. This finding is consistent with the negative result from studies of HSV-2 treatment to reduce HIV acquisition risk [29] and supports the premise of an ongoing trial of HSV-2 suppression in dually HIV-1/HSV-2-infected persons to reduce HIV infectiousness [30]. Furthermore, a mathematical model of HSV-2 and HIV-1 transmission in sub-Saharan Africa suggested a more substantial role for HSV-2 in facilitating HIV spread than other sexually transmitted infections. In contrast, according to the authors, HIV had only a modest impact on HSV-2 prevalence [31].

As the most common nonviral STD worldwide, Trichomonas vaginalis infection could have a significantly population-level impact on HIV transmission. In a case–control study of female HIV-1 seroconverters, the prevalence of trichomoniasis before HIV infection was 11.3% in seroconverters and 4.5% in controls [32]. In multivariate analysis, the adjusted odds ratio for HIV acquisition in women with T. vaginalis was 2.7.

Back to Top | Article Outline

Male circumcision

Male circumcision has been shown to significantly reduce female-to-male HIV transmission, but it had not been well studied in MSM. In MSM, there is disproportionate infection risk from receptive anal sex for which circumcision would not be expected to be protective. A recent meta-analysis of 15 studies that quantitatively examined the association between circumcision and HIV in MSM found no significant overall effect, with a weighted overall odds ration of 0.95 (95% confidence interval 0.81–1.11) among a total of 52 726 MSM participants, 52% of whom were circumcised [33•].

Although most data on male circumcision and HIV transmission are from sub-Saharan Africa, in an analysis of clinic records for African–American men attending STD clinics in Baltimore, circumcision was not associated with HIV infection status overall, but among men with known HIV exposure to an HIV-infected female partner, circumcision was associated with a statistically significant 51% reduction in risk for HIV infection [34•].

Back to Top | Article Outline

Antiretroviral treatment and prevention

There has been increasing interest in the extent to which ART reduces infectiousness and HIV transmission. A mathematical model of universal HIV testing and immediate ART regardless of CD4 cell count in South Africa predicted that both HIV incidence and mortality would be reduced to less than one case per 1000 people per year within 10 years of full implementation of the strategy, and reduce the prevalence of HIV to less than 1% within 50 years [35•]. In an observational study of HIV-discordant couples in Rwanda and Zambia, ART use was associated with a 79% reduction in HIV incidence in the initially HIV-uninfected partner [36•]. Definitive randomized, controlled data are being generated in the HPTN 052 trial that compares the HIV infection rates of two groups of HIV-serodiscordant couples. The index case of the first group starts taking ART as soon as the couple is enrolled in the study, whereas the index case of the second group starts taking ART when the CD4+ cell count is below 250 cells/μl [37].

Despite enthusiasm for this approach, it must be noted that ART use does not eliminate transmission risk. Among 145 HIV-infected men enrolled in an assisted reproductive technology program, 5% had detectable HIV-1 RNA in semen, although they had no other STD and their blood viral load was undetectable for at least 6 months on ART [38]. Also, there are concerns that ART use may increase libido and risky sex practices because of perceived reduction in infectiousness. However, in a study in South Africa, unprotected sex at last sex among patients on ART decreased significantly from a baseline after 1 year [39], and there was a decrease in risk behavior with ART use in the observational discordant couples study [36•].

Back to Top | Article Outline

Serosorting

‘Serosorting’, that involves some variation of being exposed only to sexual partners who are of the same HIV status, has been adopted by some as a risk reduction strategy, although the effectiveness of this approach is unknown. A study assessing whether MSM who serosort differed in their HIV infection risk was conducted at a large gay pride festival in 2006 [40]. About one-third of HIV-uninfected men engaged in serosorting. Men who serosorted were more likely to believe that it offered protection, perceived themselves as being at no relatively higher risk, and had more unprotected anal intercourse partners. However, over half reported their frequency of HIV testing as yearly or less frequently and therefore were potentially unknowingly recently infected. The effectiveness of serosorting for HIV prevention depends on the accuracy of infection status disclosures. A mathematical model of the risks of HIV transmission under various circumstances differed by the type of disclosures made [41•]. Accounting for rates of unrecognized HIV infection, treatment status, and differences in infectivity by stage of infection, in some circumstances serosorting can increase rather than decrease HIV transmission risk.

Back to Top | Article Outline

Superinfection

The risk and clinical significance of superinfection with another infecting HIV strain after primary infection is established are not fully understood and are especially relevant to serosorting by HIV-infected individuals and to vaccine development. Previous studies indicated that superinfection did have important clinical consequences but was generally limited to the initial infection period [42,43]. However, in a cohort of 36 high-risk Kenyan women screened for HIV-1 superinfection over a 5-year period beginning at primary infection, seven cases of superinfection were detected. In this study, superinfection occurred throughout the course of the first infection: during acute infection in two cases, between 1 and 2 years after infection in three cases, and as late as 5 years after infection in two cases [44•]. On the contrary, in a study of 49 HIV-infected MSM on ART having unprotected sex in stable, seroconcordant relationships, there were no cases of superinfection [45•], suggesting that it is not common in this specific setting.

Back to Top | Article Outline

Conclusion

In conclusion, although the global prevalence of HIV has stabilized, the burden of disease and number of new infections remains high, with significant regional differences in epidemiologic trends and transmission risk groups. The global scaling up of programmes to prevent infection and provide care and treatment to infected individuals is inconsistent and incomplete, but is having an impact where there is substantial coverage. With ongoing commitment of resources, new epidemiologic insights, such as the relationship between treatment with antiretroviral drugs, HIV viral load, and infectiousness, hold the promise of heightened effectiveness of and synergies in HIV/AIDS programs worldwide.

Back to Top | Article Outline

Acknowledgement

Disclaimer: The findings and conclusions in this article are those of the author and do not necessarily represent the views of the CDC.

Back to Top | Article Outline

References and recommended reading

Back to Top | Article Outline

Papers of particular interest, published within the annual period of review, have been highlighted as:

Back to Top | Article Outline

• of special interest

Back to Top | Article Outline

•• of outstanding interest

Back to Top | Article Outline

Additional references related to this topic can also be found in the Current World Literature section in this issue (pp. 334–335).

1•• UNAIDS/WHO. AIDS epidemic update: December 2007. Geneva: UNAIDS; 2007. http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf. This UNAIDS/WHO report contains the latest available HIV/AIDS surveillance data globally and by region, together with background information by region.

2•• UNAIDS/WHO. Report on the global HIV/AIDS epidemic 2008. Geneva: UNAIDS; 2008. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/. This extensive UNAIDS/WHO report includes detailed HIV/AIDS surveillance data as well as information about HIV/AIDS programs, policy, and societal impact.

3• Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000–2006: a systematic review. PLoS Med 2007; 4:e339.

4 Ghys PD, Walker N, McFarland W, et al. Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections. Sex Transm Infect 2008; 84:i1–i4.

5 Jahn A, Floyd S, Crampin AC, et al. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008; 371:1603–1611.

6• Orroth KK, Freeman EE, Bakker R, et al. Understanding differences between contrasting HIV epidemics in East and West Africa: results from a simulation model of the Four Cities Study. Sex Transm Infect 2007; 83(Suppl 1):i5–i16.

7• Leclerc PM, Garenne M. Commercial sex and HIV transmission in mature epidemics: a study of five African countries. Int J STD AIDS 2008; 19:660–664.

8 Sanders EJ, Graham SM, Okuku HS, et al. HIV-1 infection in high risk men who have sex with men in Mombasa, Kenya. AIDS 2007; 21:2513–2520.

9• Dunkle KL, Stephenson R, Karita E, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008; 371:2183–2191.

10 De Walque D. Sero-discordant couples in five African countries: implications for prevention strategies. Population Dev Rev 2007; 33:501–523.

11• Nagelkerke N, de Vlas SJ, Jha P, et al. Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa. AIDS 2009; 23:125–130.

12•• Kirby D. Changes in sexual behaviour leading to the decline in the prevalence of HIV in Uganda: confirmation from multiple sources of evidence. Sex Transm Infect 2008; 84(Suppl 2):ii35–ii41.

13 Ma X, Zhang Q, He X, et al. Trends in prevalence of HIV, syphilis, hepatitis C, hepatitis B, and sexual risk behavior among men who have sex with men: results of three consecutive respondent-driven sampling surveys in Beijing, 2004 through 2006. J Acquir Immune Defic Syndr 2007; 45:581–587.

14 Kruglov YV, Kobyshcha YV, Salyuk T, et al. The most severe HIV epidemic in Europe: Ukraine's national HIV prevalence estimates for 2007. Sex Transm Infect 2008; 84(Suppl 1):i37–i41.

15 EuroHIV. HIV/AIDS surveillance in Europe: end-year report 2006, No. 75. Saint-Maurice: Institut de Veille Sanitaire; 2007.

16 Soto RJ, Ghee AE, Nuñez CA, et al. Sentinel surveillance of sexually transmitted infection/HIV and risk behaviors in vulnerable populations in 5 Central American countries. J Acquir Immune Defic Syndr 2007; 46:101–111.

17• Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520–529.

18 Prejean J, Song R, An Q, Hall HI. Subpopulation estimates from the HIV incidence surveillance system: United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:985–989.

19 Holtgrave D, Hall HI, Rhodes PH, Wolitski R. Updated annual HIV transmission rates in the United States, 1977–2006. J Acquir Immune Defic Syndr 2009; 50:236–238.

20•• Bezemer D, de Wolf F, Boerlijst MC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008; 22:1071–1077.

21•• Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118–129.

22 Lewis F, Hughes GJ, Rambaut A, et al. Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med 2008; 5:e50.

23• Brenner BG, Roger M, Routy JP, et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007; 195:951–959.

24• Abu-Raddad LJ, Longini IM. No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 2008; 22:1055–1061.

25•• Butler DM, Smith DM, Cachay ER, et al. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 2008; 22:1667–1671.

26 Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008; 35:55–60.

27 Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008; 22:2179–2185.

28 Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 2008; 35:946–959.

29 Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109–2119.

30 ClinicalTrials.gov. Herpes simplex virus type 2 (HSV-2) suppression to prevent HIV transmission. http://clinicaltrials.gov/ct2/show/NCT00194519. [Accessed 8 March 2009]

31 Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008; 3:e2230.

32 Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548–554.

33• Millett GA, Flores SA, Marks G, et al. Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis. JAMA 2008; 300:1674–1684.

34• Warner L, Ghanem KG, Newman DR, et al. Male circumcision and risk of HIV infection among heterosexual African–American men attending Baltimore sexually transmitted disease clinics. J Infect Dis 2009; 199:59–65.

35• Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373:48–57.

36• Sullivan P, Kayitenkore K, Chomba E, et al. Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia. Presented at 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Canada; 8–11 February 2009 [abstract 52bLB]. Observational data indicated that ART use reduced HIV transmission in HIV-discordant couples in Africa by 79%.

37 HIV Prevention Trials Network. HPTN 052: a randomized trial to evaluate the effectiveness of antiretroviral therapy plus HIV primary care versus HIV primary care alone to prevent the sexual transmission of HIV-1 in serodiscordant couples. http://www.hptn.org/research_studies/HPTN052.asp. [Accessed 14 March 2009]

38 Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008; 22:1677–1679.

39 Eisele TP, Mathews C, Chopra M, et al. Changes in risk behavior among HIV-positive patients during their first year of antiretroviral therapy in Cape Town South Africa. AIDS Behav 2008. [Epub ahead of print]

40 Eaton LA, Kalichman SC, Cain DN, et al. Serosorting sexual partners and risk for HIV among men who have sex with men. Am J Prev Med 2007; 33:479–485.

41• Butler DM, Smith DM. Serosorting can potentially increase HIV transmissions. AIDS 2007; 21:1218–1220.

42 Grobler J, Gray CM, Rademeyer C, et al. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 2004; 190:1355–1359.

43 Smith DM, Wong JK, Hightower GK, et al. Incidence of HIV superinfection following primary infection. JAMA 2004; 292:1177–1178.

44• Piantadosi A, Chohan B, Chohan V, et al. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 2007; 3:e177. This study of female sex workers in Kenya showed that HIV superinfection may occur up to 5 years after primary infection.

45• Willberg CB, McConnell JJ, Eriksson EM, et al. Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus. PLoS Pathog 2008; 4:e1000185. Superinfection did not occur but there were T-cell immune responses in this study of HIV-infected MSM on ART and repeatedly exposed in stable, seroconcordant relationships.

Keywords:

AIDS; global epidemiology; HIV; transmission

© 2009 Lippincott Williams & Wilkins, Inc.

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.